Table 3 Reported management of inpatients with acute bronchiolitis in 2001 and 2006

	2001 survey (n = 102)					2006 survey (n = 153)					p Value
	Always	Sometimes	High risk	Never	Missing	Always	Sometimes	High risk	Never	Missing	p Value
Salbutamol	56	43	1	2	0	27	110	5	11	0	<0.001
	54.9	42.2	1.0	2.0	0.0	17.7	71.9	3.3	7.2	0.0
Ipratropium bromide	5	49	2	37	9	4	45	3	98	3	0.006
	4.9	48.0	2.0	36.3	8.8	2.6	29.4	2.0	64.1	2.0
Adrenaline	1	35	3	51	12	1	33	4	107	8	0.100
	1.0	34.3	2.9	50.0	11.8	0.7	21.6	2.6	69.9	5.2
Steroids (any)	28	53	6	15	0	11	69	12	61	0	<0.001
	27.5	52.0	5.9	14.7	0.0	7.2	45.1	7.8	39.9	0.0
Inhaled	27	51	4	20	0	10	60	9	74	0	<0.001
	26.5	50.0	3.9	19.6	0.0	6.5	39.2	5.9	48.4	0.0
Systemic	5	51	11	35	0	3	58	11	81	0	0.020
	4.9	50.0	10.8	34.3	0.0	2.0	37.9	7.2	52.9	0.0
Theophylline	1	13	4	81	3	0	8	6	138	1	0.074
	1.0	12.8	3.9	79.4	2.9	0.0	5.2	3.9	90.2	0.7
Ribavirin	0	2	6	92	2	0	1	12	139	1	0.599
	0.0	2.0	5.9	90.2	2.0	0.0	0.7	7.8	90.9	0.7
Physiotherapy	43	48	4	6	1	22	90	10	30	1	<0.001
	42.2	47.1	3.9	5.9	1.0	14.4	58.8	6.5	19.6	0.7

Data are presented as n (first line) and row per cent (second line) for each treatment. Only questionnaires from hospital based physicians are included and therefore numbers are lower than in table 2.
p Values are derived from Fisher’s exact test.